AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Ivermectin: Access, Awareness, and Alternative Treatments
This chapter examines the implications of funding cuts on the medical industry and the evolving view of ivermectin as a treatment for COVID-19. It discusses the challenges patients face in accessing ivermectin due to regulatory barriers, the safety profile compared to traditional antibiotics, and the potential for reclassification as an over-the-counter medication. Additionally, the chapter explores the author's transition to a cash-only practice and the ensuing benefits for patient care amidst frustrations with insurance companies.